March of Dimes Celebrates RI for Reductions in Preterm Birth Rate

Release Date: 05/01/2017

The March of Dimes presented Rhode Island with its Virginia Apgar Prematurity Campaign Leadership Award at a ceremony this morning for the state’s dramatic reduction in the rate of preterm births, a health issue closely tied to brain, lung, hearing, and vision issues in newborns.
 
Rhode Island’s preterm birth rate fell from 9.6% in 2010 to 8.6% in 2015, a 10% drop. The national preterm birth average for 2015 was 9.6%.
 
“We are pleased to recognize the commitment, leadership, and collaboration required to reduce the rate of prematurity in Rhode Island. We are fully aware of the complexity of this issue and applaud the state for its notable accomplishment,” said Jordana Frost, Maternal and Child Health Director for the March of Dimes in Rhode Island.
 
Despite Rhode Island’s progress in reducing its preterm birth rate, disparities still exist. For example, the preterm birth rate among African Americans was 11.4% and it was 9.7% among Latinos. The preterm birth rate among white Rhode Islanders was 8.4%. Nationally, the preterm birth rate among African American women (13%) was about 50 percent higher than the rate of preterm births among white women (9%).
 
“This award is a testament to the incredible commitment and collaboration that exists throughout Rhode Island among OB-GYNs and other healthcare providers, healthcare facilities, insurers, the Rhode Island Department of Health and other state agencies, community groups, the Rhode Island Task Force on Premature Births, and so many others,” said Nicole Alexander-Scott, MD, MPH, Director of the Rhode Island Department of Health. “Moving forward, we need to narrow our focus even more on preterm birth disparities, including those based on race, ethnicity, city or town of residence, and insurance status. Every single baby in Rhode Island absolutely deserves an equal opportunity to have as healthy a start as possible, and to be on a trajectory that will allow them to thrive through childhood and beyond.”
 
“The Rhode Island Task Force on Premature Births includes a variety of groups and projects all aimed at ameliorating various adverse situations that can contribute to preterm birth,” said Katharine Wenstrom, MD, chair of the Rhode Island Task Force on Premature Births, director of the Division of Maternal-Fetal Medicine at Women & Infants Hospital, and professor of obstetrics and gynecology at the Warren Alpert Medical School of Brown University. “Some are local grass roots projects, some are sponsored by local agencies, and some are headed by the Rhode Island Department of Health, but all are focused on working together in collaboration to share energy and resources, to be as effective as we can be in reducing the preterm birth rate in Rhode Island.”
 
A preterm birth is when labor that starts too early, before 37 weeks of pregnancy, giving the baby less time to develop in the womb. Preterm babies may have more health problems or need to stay in the hospital longer than babies born at full term. Specific complications include breathing problems, low blood pressure, bleeding in the brain, and anemia.
 
The preterm birth rate in the United States decreased from 2007 to 2014. This decline was in part due to declines in the number of births to teens and young mothers. Data indicate a slight increase in the national preterm birth rate from 2014 to 2015.
 
The Rhode Island Task Force on Premature Births has been working to address preterm births since 2006, when Rhode Island’s preterm birth rate was 12.5%. The work of the Task Force includes expanding access to contraception and working to reduce multiple pregnancies by assisted reproductive technology, which is a major risk factor for preterm births. Other risk factors include an interval of less than six months between pregnancies, smoking cigarettes, using illicit drugs, poor nutrition, stressful life events, and other social and environmental factors.
 
Another major focus on the Rhode Island Task Force on Premature Births is addressing barriers to access to 17-hydroxyprogesterone, which is also known as 17P. 17P is an evidence-based intervention to help prevent recurrent preterm birth. Barriers to access to 17P include cost, insurance coverage, and availability.
 
The six other states or territories to receive the Virginia Apgar Prematurity Campaign Leadership Award are Montana, Nevada, North Dakota, Oklahoma, Puerto Rico, and Virginia.

 

 

About Women & Infants Hospital 

Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation’s leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women’s medicine, Women & Infants is the 9th largest stand-alone obstetrical service in the country and the largest in New England with approximately 8,500 deliveries per year. A Designated Baby-Friendly® USA hospital, U.S.News & World Report 2014-15 Best Children’s Hospital in Neonatology and a 2014 Leapfrog Top Hospital, in 2009 Women & Infants opened what was at the time the country’s largest, single-family room neonatal intensive care unit.

Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.